Resumen
La neuralgia posherpética (NPH) es la principal complicación del herpes zoster (HZ), el cual normal- mente cursa con dolor y rash por un par de semanas, sin embargo un porcentaje importante de personas presentan dolor de tipo neuropático, prolongado y de difícil manejo clínico, cuadro denominado NPH. Al igual que en el HZ, la incidencia de la NPH aumenta en personas mayores, aspecto relevante, ya que a pesar de los múltiples manejos disponibles, ninguno se considera 100% eficaz. El objetivo principal de esta revisión es hacer un análisis de los elementos farmacológicos y no farmacológicos disponibles para el manejo de la NPH.
Citas
VAN WICK AJM, WALLACE M, MEKHAIL N, VAN KLEEF M. Herpes Zoster and Post-Herpetic Neuralgia. Pain Practice. 2011;11:88-97.
DROLET E, BRISSON M, SCHMADER KE, LEVIN MJ, JOHNSON R, OXMAN MN, ET AL. The impact of herpes zoster and postherpetic neuralgia on health- related quality of life: a prospective study. CMAJ. 2010;182.
BARON R, MAYORAL V, LEIJON G, BINDER A, STEIGERWALD I, SERPELL M. 5% lidocaine medicated plaster versus pregabalin inpost-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. CMRO. 2009; 25:1663-1676.
KATHERINE E. GALLUZZI, DO, CMD. Managing Herpes Zoster and Postherpetic Neuralgia. J Am Osteopath Assoc. 2009; 109 (Supl 2):7-12
TOMAZ RG, DE NAZAREHT PEDRAS RB, DA SILVA JF, DE AGUIAR MCF. Sympathetic Nerve Blocks in Mandibular Herpes Zoster and Postherpetic Neu- ralgia. HEADACHE: The Journal of Head and Face Pain 2007;47:728-730.
SAMPATHKUMAR P, DRAGE LA, MARTIN DP.Herpes Zoster (Shingles) and Postherpetic Neuralgia.Mayo Clinic Proceedings. 2009;84:274-280.
SCHMADER K. Herpes Zoster in Older Adults.Clin Infect Dis. 2001; 32:1481-1486.
DWORKIN RH, GNANN JW JR, OAKLANDER AL, RAJA SN, SCHMADER KE, WHITLEY RJ. Diagno- sis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008; 9 (Suppl):S37-S44.
GNANN JW JR, WHITLEY RJ. Herpes Zoster. N Engl J Med. 2002; 347:340-346.
WOOD MJ, JOHNSON RW, MCKENDRICK MW, TAYLOR J, MANDAL BK, CROOKS J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994; 330:896-900.
WHITLEY RJ, WEISS H, GNANN JW JR, ET AL. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo- controlled trial. Ann Intern Med. 1996;125:376-383.
LIN PL, FAN SZ, HUANG CH, ET AL. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle- controlled study. Reg Anesth Pain Med. 2008;33:320–325.
OXMAN MN, LEVIN MJ, JOHNSON GR, ET AL.A vaccine to prevent herpes zoster and posther- petic neuralgia in older adults. N Engl J Med. 2005; 352:2271–2284.
OXMAN MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology.1995; 45 (Suppl):S41–S46.
LEVIN MJ, SMITH JG, KAUFHOLD RM, ET AL.Decline in varicella-zoster virus (VZV)–specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003; 188:1336–1344.
TAKAHASHI M, IKETANI T, SASADA K, ET AL. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. J Infect Dis. 1992; 166 (Suppl):S58–S62.
LEVIN MJ, BARBER D, GOLDBLATT E, ET AL.Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998; 178 (Suppl):S109–S112.
TRANNOY E, BERGER R, HOLLANDER G, ET AL. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of vari- cella zoster virus: a randomized, controlled, dose- response trial. Vaccine. 2000; 18:1700–1706.
NIV D, MALTSMAN-TSEIKHIN A. Postherpetic Neuralgia: The Never-Ending Challenge. Pain Practice. 2005;5:327-340.
PAPPAGALLO M, HALDEY EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs. 2003;17:771-780.
HEMPENSTALL K, NURMIKKO TJ, JOHNSON RW, A’HERN RP, RICE AS. Analgesic therapy in pos- therpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164.
ROWBOTHAM M, HARDEN N, STACEY B, BERNSTEIN P, MAGNUS-MILLER L. Gabapentin for the Treatment of Postherpetic Neuralgia. JAMA. 1998;280:1837-42.
FRAMPTON JE, FOSTER RH. Pregabalin: In the Treatment of Postherpetic Neuralgia. Drugs. 2005;65:111-118.
ROWBOTHAM MC, REISNER-KELLER LA, FIELDS HL. Both intravenous lidocaine and mor- phine reduce the pain of postherpetic neuralgia. 1991; 41:1024.
WATSON CP, BAUL N. Efficacy of oxycodone in neuropathic pain: a randomized trial in posther- petica neuralgia. Neurology.1998; 50:1837-41.
WATSON CP, MOULIN D, WATT-WATSON J, GORDON A, EISENHOFFER J. Controlled-release oxycodone relieves neuropathic pain: a randomi- zed controlled trial in painful diabetic neuropathy. Pain.2003; 105:71-78.
BOUREAU F, LEGALLICIER P, KABIR-AHMADI M. Tramadol in post-herpetic neuralgia: a rando- mized, double-blind, placebo-controlled trial. Pain. 2003; 104:323-331.
RAJA SN, HAYTHORNTHWAITE JA, PAPA- GALLO M, CLARK MR, TRAVISON TG, SABEEN S, ET AL. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology. 2002; 59:1015-21.
WU CL, RAJA SN. An update on the treatment of postherpetic neuralgia. J Pain. 2008; 9 (Supl 1):19- 30.
ROWBOTHAM MC, DAVIE PS, VERKEMPINCK C, GALER BS. Lidocaine patch: double-blind con- trolled study of a new treatment method for post- herpetic neuralgia. Pain. 1996; 65:39-44.
KHALIQ W, ALAM S, PURI N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007; 18: CD004846.
WATSON CP, TYLER KL, BLICKERS DL, MILIKAN LE, SMITH S, COLEMAN E. A randomi- zed vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15:510-26.
PASQUALUCCI A, PASQUALUCCI V, GALLA F, ET AL. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand. 2000;44:910–918
VAN WIJCK AJ, OPSTELTEN W, MOONS KG, ET AL. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a ran- domised controlled trial. Lancet. 2006;367:219–224.
KOTANI N, KUSHIKATA T, HASHIMOTO H, ET AL. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343:1514– 1519
BARON R, WASNER G. Prevention and treatment of postherpetic neuralgia. Lancet. 2006;367:186-188.
WU CL, MARSH A, DWORKIN RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000;87:121–129
HARKE H, GRETENKORT P, LADLEIF HU, KOESTER P, RAHMAN S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002;94:694–700
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.